Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 4, 2006 - Issue 6
Submit an article Journal homepage
384
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Structured treatment interruptions in chronic HIV management: where next?

Nitika Pant Pai Postdoctoral Fellow, Canadian Trials Network, McGill University Health Centre, Division of Infectious Diseases and Immunodeficiency Service, Montreal Chest Institute, 3650, St Urbain Street, Montreal, Quebec, H2X 2P4, Canada. [email protected]
&
Marina B Klein McGill University Health Centre, Division of Infectious Diseases and Immunodeficiency Service, Montreal Chest Institute, 3650 St Urbain Street, Montreal, Quebec, H2X 2P4, Canada. [email protected]
Pages 909-912 | Published online: 10 Jan 2014

References

  • Lori F, Maserati R, Foli A, Seminari E, Timpone J, Lisziewicz J. Structured treatment interruptions to control HIV-1 infection. Lancet355(9200), 287–288 (2000).
  • Miller V. Structured treatment interruptions in antiretroviral management of HIV-1. Curr. Opin. Infect. Dis.14(1), 29–37 (2001).
  • Pai NP, Tulsky JP, Lawrence J, Colford JM Jr, Reingold AL. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults. Cochrane Database Syst. Rev.4, CD005482 (2005).
  • Pai NP, Lawrence J, Reingold AL, Tulsky JP. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database Syst. Rev.3, CD006148 (2006).
  • Jacobson JM, Pat Bucy R, Spritzler J et al. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068. J. Infect. Dis.194(5), 623–632 (2006).
  • Hoen B, Fournier I, Lacabaratz C et al. Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial. J. Acquir. Immune Defic. Syndr.40(3), 307–316 (2005).
  • Kyriakides TC, Babiker A, Singer J et al. An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial. Control. Clin. Trials24(4), 481–500 (2003).
  • Lawrence J, Mayers DL, Hullsiek KH et al. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. N. Engl. J. Med.349(9), 837–846 (2003).
  • Katlama C, Dominguez S, Gourlain K et al. Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097). AIDS18(2), 217–226 (2004).
  • Deeks SG. The risk of treatment versus the risk of HIV replication. Lancet367(9527), 1955–1956 (2006).
  • Benson CA. Structured treatment interruptions – new findings. Top. HIV Med.14(3), 107–111 (2006).
  • Ananworanich J, Siangphoe U, Hill A et al. Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study. J. Acquir. Immune Defic. Syndr.39(5), 523–529 (2005).
  • Nuesch R, Ananworanich J, Sirivichayakul S et al. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment. Clin. Infect. Dis.40(5), 728–734 (2005).
  • Vogel M, Lichterfeld M, Kaufmann DE et al. Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion. Eur. J. Med. Res.11(7), 273–278 (2006).
  • The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ Count Guided Interruption of Antiretroviral Treatment. Presented at N. Engl. J. Med.355, 2283–2296 (2006).
  • Danel C, Moh R, Minga A et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. Lancet367(9527), 1981–1989 (2006).
  • Ananworanich J, Gayet-Ageron A, Le Braz M et al. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet368(9534), 459–465 (2006).
  • Oxenius A, Price DA, Gunthard HF et al. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl Acad. Sci. USA99(21), 13747–13752 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.